Purdue Pharma, the maker of Oxycontin, conducted what may be the most extensive investigation yet of the Sackler family, exploring whether they committed crimes or financial improprieties, but the company has kept most of its findings secret.Read More
Critics say the settlement doesn't hold company executives or members of the Sackler family accountable for their aggressive marketing of OxyContin, which helped fuel the nation's opioid epidemic.Read More
This was meant to be the year we answered a big question about the deadly opioid epidemic: Will drug companies that make and sell prescription pain medications be held liable? That clarity never came.Read More
According to a court filing Monday, the family pulled about $10.7 billion from Purdue since 2008 — ramping up withdrawals even after executives pleaded guilty to misleading regulators about OxyContin.Read More
The revelation comes after almost two dozen states reached a tentative settlement with the maker of OxyContin.Read More
Confronted with a torrent of lawsuits across the U.S., several major drug companies are in discussions with authorities to resolve thousands of opioid-related suits filed against them. A government source close to the negotiations tells NPR that Purdue Pharma, Johnson & Johnson, Endo International and Allergan are looking to cut deals.Read More
The lawsuit alleges that sometimes one company would decide to raise prices on a particular drug, and other companies would follow suit. Other times, companies would agree to divide up the market rather than competing for market share by lowering prices.Read More
At the same time Washington Attorney General Bob Ferguson is suing three Fortune 15 pharmaceutical distributors for allegedly “fueling the state’s opioid epidemic,” majority Democrats in the Washington Legislature this year left intact a generous tax break for distributors of opioids and other prescription drugs while raising taxes on other business sectors.Read More
The Massachusetts attorney general alleges that the family behind Purdue Pharma knew that OxyContin was causing overdoses, yet continued to cash in. New documents in the case were released Thursday.Read More
The report released by Missouri Democratic Sen. Claire McCaskill says the cozy relationship between pain advocacy groups and pharmaceutical companies may have played a key role in the opioid crisis.Read More